Cargando…

P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS

Detalles Bibliográficos
Autores principales: Jiang, Erlie, Chen, Shulian, Zhang, Xiaoyu, Zhai, Weihua, Niu, Ting, Xu, Yajing, Gao, Guangxun, Fan, Shengjin, Zhou, Zeping, Zhou, Fang, Liu, LI, Yang, Wei, Liu, Qifa, Zhang, XI, Bai, Hai, XI, Rui, He, Yi, Feng, Sizhou, Han, Mingzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430501/
http://dx.doi.org/10.1097/01.HS9.0000972080.35265.1c
_version_ 1785090979123953664
author Jiang, Erlie
Chen, Shulian
Zhang, Xiaoyu
Zhai, Weihua
Niu, Ting
Xu, Yajing
Gao, Guangxun
Fan, Shengjin
Zhou, Zeping
Zhou, Fang
Liu, LI
Yang, Wei
Liu, Qifa
Zhang, XI
Bai, Hai
XI, Rui
He, Yi
Feng, Sizhou
Han, Mingzhe
author_facet Jiang, Erlie
Chen, Shulian
Zhang, Xiaoyu
Zhai, Weihua
Niu, Ting
Xu, Yajing
Gao, Guangxun
Fan, Shengjin
Zhou, Zeping
Zhou, Fang
Liu, LI
Yang, Wei
Liu, Qifa
Zhang, XI
Bai, Hai
XI, Rui
He, Yi
Feng, Sizhou
Han, Mingzhe
author_sort Jiang, Erlie
collection PubMed
description
format Online
Article
Text
id pubmed-10430501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305012023-08-17 P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS Jiang, Erlie Chen, Shulian Zhang, Xiaoyu Zhai, Weihua Niu, Ting Xu, Yajing Gao, Guangxun Fan, Shengjin Zhou, Zeping Zhou, Fang Liu, LI Yang, Wei Liu, Qifa Zhang, XI Bai, Hai XI, Rui He, Yi Feng, Sizhou Han, Mingzhe Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430501/ http://dx.doi.org/10.1097/01.HS9.0000972080.35265.1c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Jiang, Erlie
Chen, Shulian
Zhang, Xiaoyu
Zhai, Weihua
Niu, Ting
Xu, Yajing
Gao, Guangxun
Fan, Shengjin
Zhou, Zeping
Zhou, Fang
Liu, LI
Yang, Wei
Liu, Qifa
Zhang, XI
Bai, Hai
XI, Rui
He, Yi
Feng, Sizhou
Han, Mingzhe
P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS
title P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS
title_full P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS
title_fullStr P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS
title_full_unstemmed P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS
title_short P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS
title_sort p1298: the efficacy and safety of modified melphalan and busulfan-based conditioning regimen for allogeneic-hsct in refractory/relapsed or persistent mrd positivity aml patients
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430501/
http://dx.doi.org/10.1097/01.HS9.0000972080.35265.1c
work_keys_str_mv AT jiangerlie p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT chenshulian p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT zhangxiaoyu p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT zhaiweihua p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT niuting p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT xuyajing p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT gaoguangxun p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT fanshengjin p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT zhouzeping p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT zhoufang p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT liuli p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT yangwei p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT liuqifa p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT zhangxi p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT baihai p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT xirui p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT heyi p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT fengsizhou p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients
AT hanmingzhe p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients